Doximity (NASDAQ:DOCS) PT Raised to $30.00 at JPMorgan Chase & Co.

Doximity (NASDAQ:DOCS) had its target price raised by research analysts at JPMorgan Chase & Co. from $27.00 to $30.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential downside of 17.15% from the company’s previous close.

Other equities analysts have also recently issued research reports about the stock. Barclays lifted their price objective on shares of Doximity from $31.00 to $35.00 and gave the stock an “equal weight” rating in a research note on Friday, August 9th. Needham & Company LLC raised Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a report on Friday, August 9th. Bank of America raised their price objective on Doximity from $29.00 to $32.00 and gave the stock a “neutral” rating in a research note on Friday, August 9th. Evercore ISI boosted their target price on Doximity from $29.00 to $34.00 and gave the stock an “in-line” rating in a research report on Friday, August 9th. Finally, William Blair reaffirmed an “outperform” rating on shares of Doximity in a report on Friday, May 17th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $31.27.

Doximity Stock Up 0.5 %

NASDAQ:DOCS opened at $36.21 on Monday. The business’s 50-day moving average price is $28.94 and its 200 day moving average price is $27.67. Doximity has a 52-week low of $19.71 and a 52-week high of $37.25. The firm has a market cap of $6.71 billion, a P/E ratio of 50.29, a PEG ratio of 5.12 and a beta of 1.22.

Insider Buying and Selling at Doximity

In related news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the transaction, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at $10,836,945. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Doximity news, CFO Anna Bryson sold 30,000 shares of Doximity stock in a transaction on Friday, August 9th. The shares were sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the completion of the sale, the chief financial officer now owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Kira Scherer Wampler sold 2,500 shares of the business’s stock in a transaction on Monday, July 1st. The shares were sold at an average price of $28.00, for a total transaction of $70,000.00. Following the transaction, the director now owns 10,258 shares in the company, valued at $287,224. The disclosure for this sale can be found here. Insiders have sold a total of 77,951 shares of company stock valued at $2,471,018 in the last 90 days. 39.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. LRI Investments LLC bought a new stake in shares of Doximity in the 1st quarter valued at approximately $27,000. First Horizon Advisors Inc. lifted its stake in Doximity by 111.3% in the fourth quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock valued at $28,000 after acquiring an additional 524 shares during the last quarter. Blue Trust Inc. grew its position in Doximity by 621.4% in the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after acquiring an additional 1,193 shares in the last quarter. GAMMA Investing LLC acquired a new position in shares of Doximity during the 4th quarter worth $40,000. Finally, Quarry LP increased its stake in shares of Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after purchasing an additional 131,253 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.